Peter Kirkpatrick

Author PubWeight™ 108.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vorinostat. Nat Rev Drug Discov 2007 2.83
2 Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006 2.58
3 Abatacept. Nat Rev Drug Discov 2006 2.13
4 Pegloticase. Nat Rev Drug Discov 2011 1.76
5 Vemurafenib. Nat Rev Drug Discov 2011 1.68
6 Tetrabenazine. Nat Rev Drug Discov 2009 1.60
7 Eculizumab. Nat Rev Drug Discov 2007 1.56
8 Dabigatran etexilate. Nat Rev Drug Discov 2008 1.41
9 Sipuleucel-T. Nat Rev Drug Discov 2010 1.37
10 Tocilizumab. Nat Rev Drug Discov 2009 1.36
11 Effect of decompressive craniectomy on intracranial pressure and cerebrospinal compensation following traumatic brain injury. J Neurosurg 2008 1.35
12 Cabazitaxel. Nat Rev Drug Discov 2010 1.34
13 Denosumab. Nat Rev Drug Discov 2010 1.31
14 Cetuximab. Nat Rev Drug Discov 2004 1.31
15 Panitumumab. Nat Rev Drug Discov 2006 1.31
16 Everolimus. Nat Rev Drug Discov 2009 1.29
17 Liraglutide. Nat Rev Drug Discov 2010 1.27
18 Dasatinib. Nat Rev Drug Discov 2006 1.25
19 Azacitidine. Nat Rev Drug Discov 2005 1.23
20 Enfuvirtide. Nat Rev Drug Discov 2003 1.22
21 Daptomycin. Nat Rev Drug Discov 2003 1.22
22 Erlotinib hydrochloride. Nat Rev Drug Discov 2005 1.22
23 Asenapine. Nat Rev Drug Discov 2009 1.21
24 Ipilimumab. Nat Rev Drug Discov 2011 1.20
25 Duloxetine hydrochloride. Nat Rev Drug Discov 2004 1.17
26 Vismodegib. Nat Rev Drug Discov 2012 1.16
27 Oxaliplatin. Nat Rev Drug Discov 2004 1.14
28 Eribulin mesylate. Nat Rev Drug Discov 2011 1.14
29 Tolvaptan. Nat Rev Drug Discov 2009 1.13
30 Ivacaftor. Nat Rev Drug Discov 2012 1.12
31 Febuxostat. Nat Rev Drug Discov 2009 1.12
32 Golimumab. Nat Rev Drug Discov 2009 1.11
33 Lapatinib. Nat Rev Drug Discov 2007 1.10
34 Bevacizumab. Nat Rev Drug Discov 2004 1.09
35 Lacosamide. Nat Rev Drug Discov 2008 1.09
36 Ranibizumab. Nat Rev Drug Discov 2006 1.08
37 Sunitinib maleate. Nat Rev Drug Discov 2006 1.07
38 Crizotinib. Nat Rev Drug Discov 2011 1.05
39 Plerixafor. Nat Rev Drug Discov 2009 1.04
40 Brentuximab vedotin. Nat Rev Drug Discov 2012 1.04
41 Aflibercept. Nat Rev Drug Discov 2012 1.04
42 Exenatide. Nat Rev Drug Discov 2005 1.02
43 Pazopanib. Nat Rev Drug Discov 2010 1.02
44 Ustekinumab. Nat Rev Drug Discov 2009 1.02
45 Decitabine. Nat Rev Drug Discov 2006 1.02
46 Varenicline. Nat Rev Drug Discov 2006 0.99
47 Gefitinib. Nat Rev Drug Discov 2003 0.99
48 Certolizumab pegol. Nat Rev Drug Discov 2008 0.98
49 Pregabalin. Nat Rev Drug Discov 2005 0.98
50 Teriparatide. Nat Rev Drug Discov 2003 0.98
51 Belatacept. Nat Rev Drug Discov 2011 0.96
52 Ruxolitinib. Nat Rev Drug Discov 2012 0.96
53 Telavancin. Nat Rev Drug Discov 2009 0.94
54 Dronedarone. Nat Rev Drug Discov 2009 0.93
55 Ezogabine (retigabine). Nat Rev Drug Discov 2011 0.92
56 Ecallantide. Nat Rev Drug Discov 2010 0.91
57 Posaconazole. Nat Rev Drug Discov 2007 0.91
58 Tigecycline. Nat Rev Drug Discov 2005 0.91
59 Tafamidis. Nat Rev Drug Discov 2012 0.91
60 Surgery for brain edema. Neurosurg Focus 2007 0.91
61 Pegaptanib sodium. Nat Rev Drug Discov 2005 0.90
62 Prasugrel. Nat Rev Drug Discov 2009 0.90
63 Memantine hydrochloride. Nat Rev Drug Discov 2004 0.88
64 Fresh from the pipeline. Ticagrelor. Nat Rev Drug Discov 2011 0.87
65 Telbivudine. Nat Rev Drug Discov 2007 0.87
66 Alvimopan. Nat Rev Drug Discov 2008 0.86
67 Romiplostim. Nat Rev Drug Discov 2008 0.86
68 Sitagliptin. Nat Rev Drug Discov 2007 0.86
69 Quadrivalent human papillomavirus recombinant vaccine. Nat Rev Drug Discov 2006 0.85
70 Velaglucerase alfa. Nat Rev Drug Discov 2010 0.85
71 Tipranavir. Nat Rev Drug Discov 2005 0.85
72 Specificity concerns with antibodies for receptor mapping. Nat Rev Drug Discov 2009 0.85
73 Roflumilast. Nat Rev Drug Discov 2010 0.85
74 Aripiprazole. Nat Rev Drug Discov 2003 0.84
75 Belimumab. Nat Rev Drug Discov 2011 0.83
76 Pemetrexed disodium. Nat Rev Drug Discov 2004 0.83
77 Differential cyclin E expression in human in-stent stenosis smooth muscle cells identifies targets for selective anti-restenosis therapy. Cardiovasc Res 2003 0.83
78 Pirfenidone. Nat Rev Drug Discov 2011 0.83
79 Pasireotide. Nat Rev Drug Discov 2012 0.81
80 Inhaled aztreonam. Nat Rev Drug Discov 2010 0.81
81 Ofatumumab. Nat Rev Drug Discov 2010 0.81
82 Entecavir. Nat Rev Drug Discov 2005 0.81
83 Ranolazine. Nat Rev Drug Discov 2006 0.81
84 Efalizumab. Nat Rev Drug Discov 2004 0.81
85 Meningococcal group A, C, Y and W-135 conjugate vaccine. Nat Rev Drug Discov 2010 0.80
86 Eplerenone. Nat Rev Drug Discov 2003 0.80
87 Natalizumab. Nat Rev Drug Discov 2005 0.80
88 Abiraterone acetate. Nat Rev Drug Discov 2011 0.80
89 Fresh from the pipeline: Ramelteon. Nat Rev Drug Discov 2005 0.79
90 Bendamustine. Nat Rev Drug Discov 2008 0.79
91 Rasagiline. Nat Rev Drug Discov 2005 0.78
92 Omalizumab. Nat Rev Drug Discov 2004 0.78
93 Clofarabine. Nat Rev Drug Discov 2005 0.78
94 Galsulfase. Nat Rev Drug Discov 2006 0.78
95 Lisdexamfetamine dimesylate. Nat Rev Drug Discov 2007 0.78
96 Telithromycin. Nat Rev Drug Discov 2004 0.77
97 Tiotropium bromide. Nat Rev Drug Discov 2004 0.77
98 Atazanavir sulphate. Nat Rev Drug Discov 2003 0.77
99 Vernakalant. Nat Rev Drug Discov 2010 0.77
100 Atomoxetine hydrochloride. Nat Rev Drug Discov 2004 0.77
101 Nelarabine. Nat Rev Drug Discov 2006 0.77
102 Inhaled human insulin. Nat Rev Drug Discov 2006 0.76
103 Tesamorelin. Nat Rev Drug Discov 2011 0.75
104 Antiparasitic drugs: Two-pronged tactics for malaria control. Nat Rev Drug Discov 2012 0.75
105 Medicinal chemistry: Shades of chemical beauty. Nat Rev Drug Discov 2012 0.75
106 Drotrecogin alpha (activated). Nat Rev Drug Discov 2003 0.75
107 Fresh from the pipeline. Ezetimibe. Nat Rev Drug Discov 2003 0.75
108 Ambrisentan. Nat Rev Drug Discov 2007 0.75
109 Tadalafil and vardenafil. Nat Rev Drug Discov 2004 0.75
110 Sinus pericranii--"Don't judge a lump by its surface". J Craniofac Surg 2010 0.75
111 Rosuvastatin calcium. Nat Rev Drug Discov 2003 0.75